Gevokizumab Withdrawn Phase 1 / 2 Trials for Autoinflammatory / Behcet's Syndrome / Muckle Wells Syndrome Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs